Fortrea Holdings (FTRE) Non-Current Debt (2023 - 2026)
Fortrea Holdings (FTRE) reported Non-Current Debt of $1.0 billion for Q1 2026, down 0.7% on a YoY basis from $1.0 billion in Q1 2025, and down 0.52% quarter-over-quarter from $1.0 billion in Q4 2025.
Fortrea Holdings (FTRE) Non-Current Debt (2023 - 2026) Analysis & Trends
Fortrea Holdings has reported Non-Current Debt for 4 years, with the latest figure at $1.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Debt fell 0.7% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (down 0.7% YoY), and the FY2025 full-year result was $1.0 billion, changed 0.16% from the prior year.
- Non-Current Debt for Q1 2026 stood at $1.0 billion, down from $1.0 billion in the prior quarter.
- The five-year high for Non-Current Debt was $1.6 billion in Q2 2023, with the low at $1.0 billion in Q1 2026.
- Historically, Non-Current Debt has averaged $1.2 billion across 4 years, with a median of $1.1 billion in 2024.
- Annual changes were most pronounced in 2024 — Non-Current Debt slumped 32.97% — and 2025, when it declined 0.16%.
- Fortrea Holdings' Non-Current Debt stood at $1.6 billion in 2023, then slumped by 32.97% to $1.0 billion in 2024, then dropped by 0.16% to $1.0 billion in 2025, then slipped by 0.52% to $1.0 billion in 2026.
- The last three Non-Current Debt figures came in at $1.0 billion (Q1 2026), $1.0 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | 1.04 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Bn |
| Mar 31, 2026 | 1.04 Bn |
| Dec 31, 2025 | 1.05 Bn |
| Dec 31, 2025 | 1.05 Bn |
| Sep 30, 2025 | 1.05 Bn |
| Sep 30, 2025 | 1.05 Bn |
| Jun 30, 2025 | 1.10 Bn |
| Jun 30, 2025 | 1.10 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 1.05 Bn |
| Dec 31, 2024 | 1.05 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.12 Bn |
| Mar 31, 2024 | 1.56 Bn |
| Mar 31, 2024 | 1.56 Bn |
| Dec 31, 2023 | 1.57 Bn |
| Dec 31, 2023 | 1.57 Bn |